Industry News
Pharmaceutical Industry News
Novartis-backed Credence taps Phillips-Medisize to step up production drug delivery system
Novartis-backed Credence taps Phillips-Medisize to step up production drug delivery system ntaylor Tue, 10/26/2021 - 06:02
Is Sandoz spinoff finally here? Novartis gets the ball rolling with strategic review
Is Sandoz spinoff finally here? Novartis gets the ball rolling with strategic review aliu Tue, 10/26/2021 - 05:21
Biden and Democrats Push for Budget Deal This Week as Rifts Remain
Negotiators were closing in on a deal that could spend around $1.75 trillion, but lawmakers were still haggling over critical disagreements on the sprawling social policy bill.
BioNTech to start building mRNA vaccine manufacturing plant in Africa in mid-2022
BioNTech to start building mRNA vaccine manufacturing plant in Africa in mid-2022 klahucik Mon, 10/25/2021 - 17:53
Arrowhead takes aim at Wisconsin for $250M manufacturing plant: report
Arrowhead takes aim at Wisconsin for $250M manufacturing plant: report jkeenan Mon, 10/25/2021 - 13:44
AstraZeneca’s Imfinzi strikes immunotherapy’s first win in bile duct cancer, with Merck’s Keytruda behind
AstraZeneca's Imfinzi strikes immunotherapy's first win in bile duct cancer, with Merck's Keytruda behind aliu Mon, 10/25/2021 - 11:30
Tiny biotech Errant sues Bluebird for patent infringement in developing gene therapy LentiGlobin
Tiny biotech Errant sues Bluebird for patent infringement in developing gene therapy LentiGlobin kdunleavy Mon, 10/25/2021 - 11:15
Novartis looks for silver lining in $2B canakinumab repurposing after 2nd lung cancer failure
Novartis looks for silver lining in $2B canakinumab repurposing after 2nd lung cancer failure aliu Mon, 10/25/2021 - 09:57
J&J’s COVID-19 vaccine maker in South Africa opens line for anesthetics: report
J&J's COVID-19 vaccine maker in South Africa opens line for anesthetics: report jkeenan Mon, 10/25/2021 - 09:30
F.D.A. Says Pfizer Vaccine’s Benefits Outweigh Key Risks in Children 5 to 11
The findings could add momentum for F.D.A. authorization of the pediatric dose, perhaps as early as next week, a long-awaited development that would affect 28 million children.
Here’s Why Developing Countries Can Make mRNA Covid Vaccines
Pfizer and Moderna are skeptical, but we found 10 companies in Africa, Asia and South America well-positioned to produce the gold-standard mRNA shots.
Bristol Myers Squibb, after passing on Acceleron, now eyes Aurinia takeout: Bloomberg
Bristol Myers Squibb, after passing on Acceleron, now eyes Aurinia takeout: Bloomberg esagonowsky Fri, 10/22/2021 - 16:15
Oncopeptides’ shares crash as it pulls Pepaxto from the market, plans to shut down commercial units
Oncopeptides' shares crash as it pulls Pepaxto from the market, plans to shut down commercial units kdunleavy Fri, 10/22/2021 - 15:27
Pfizer’s COVID-19 vaccine is safe, effective in kids ages 5 to 11, setting up possible FDA nod
Pfizer's COVID-19 vaccine is safe, effective in kids ages 5 to 11, setting up possible FDA nod kdunleavy Fri, 10/22/2021 - 11:18
Buckle up AbbVie, Amgen: Biohaven’s oral CGRP drug is gaining traction in migraine, doctors’ survey shows
Buckle up AbbVie, Amgen: Biohaven's oral CGRP drug is gaining traction in migraine, doctors’ survey shows aliu Fri, 10/22/2021 - 10:37
Lilly breached a contract by not paying royalties on big-selling diabetes meds, court finds
Lilly breached a contract by not paying royalties on big-selling diabetes meds, court finds esagonowsky Fri, 10/22/2021 - 10:35
Sanofi and Regeneron’s Dupixent aces another test, this time in the debilitating itch condition prurigo nodularis
Sanofi and Regeneron's Dupixent aces another test, this time in the debilitating itch condition prurigo nodularis kdunleavy Fri, 10/22/2021 - 10:16
FDA greenlights Genentech’s eye implant for macular degeneration. Will it be a tough sell?
FDA greenlights Genentech's eye implant for macular degeneration. Will it be a tough sell? kdunleavy Fri, 10/22/2021 - 07:51
Fierce Pharma Asia—Hansoh’s siRNA deals; J&J preps for Legend’s CAR-T launch; Brii’s COVID antibodies
Fierce Pharma Asia—Hansoh’s siRNA deals; J&J preps for Legend’s CAR-T launch; Brii’s COVID antibodies aliu Fri, 10/22/2021 - 05:59
BMS, GRYT Health push for diversity in oncology with new initiative
BMS, GRYT Health push for diversity in oncology with new initiative sharon.coey Fri, 10/22/2021 - 04:24